scholarly journals P104 ONE-YEAR AND TWO-YEAR FOLLOW UP ANALYSIS OF CARTILAGE MORPHOLOGY USING QUANTITATIVE DESS AND FLASH 3 TESLA MR-IMAGING - A PILOT STUDY FOR THE OSTEOARTHRITIS INITIATIVE

2006 ◽  
Vol 14 ◽  
pp. S67-S68
Author(s):  
M. Kunz ◽  
E. Schneider ◽  
M.I. Hudelmaier ◽  
R.D. Jackson ◽  
J. Yu ◽  
...  
1984 ◽  
Vol 2 (3) ◽  
pp. 152-156 ◽  
Author(s):  
J H Edmonson ◽  
S J Green ◽  
J C Ivins ◽  
G S Gilchrist ◽  
E T Creagan ◽  
...  

Thirty-eight patients whose primary extremity or limb girdle osteosarcomas had been completely excised (37 amputations, one limb sparing procedure) were allocated at random to two treatment groups receiving respectively regular follow-up examinations plus a high-dose methotrexate (HDMTX) regimen or regular follow-up without primary adjuvant chemotherapy. Although the vincristine, HDMTX, leucovorin regimen was generally quite tolerable when given at three-week intervals for one year and most of the chemotherapy patients followed the planned HDMTX dose escalations from 3 to 6 to 7.5 g/m2, delayed methotrexate excretion limited dosage escalations in 25%. An estimated 52% of the 38 patients were surviving five years after randomization and an estimated 42% remained continuously relapse-free after five years. No significant differences between the outcomes of the 20 treated and the 18 untreated patients were apparent; however, power to detect differences was low. Furthermore, no significant differences in postmetastasis survival were apparent between the 12 treated and 10 untreated patients who relapsed. Approximately 20% of these failing patients appear to have been salvaged for long-term survival. This pilot study of HDMTX confirms the continuing need for controlled clinical trials in determining the therapeutic value of adjuvant chemotherapy programs for patients with primary osteosarcoma.


2013 ◽  
Vol 144 (5) ◽  
pp. S-173 ◽  
Author(s):  
Miguel Regueiro ◽  
Leonard Baidoo ◽  
Kevin E. Kip ◽  
Jason M. Swoger ◽  
David G. Binion ◽  
...  

2009 ◽  
Vol 40 (3) ◽  
pp. 479-486 ◽  
Author(s):  
Fernando Fernández-Aranda ◽  
Isabel Krug ◽  
Susana Jiménez-Murcia ◽  
Roser Granero ◽  
Araceli Núñez ◽  
...  

Nutrients ◽  
2021 ◽  
Vol 14 (1) ◽  
pp. 68
Author(s):  
Daniel J. Lamport ◽  
Szu-Yun Wu ◽  
Jenni Drever-Heaps ◽  
Orla Hugueniot ◽  
Daniel J. W. Jones ◽  
...  

The aim of this pilot study was to evaluate the effectiveness of the U.K. Change4Life Sugar Swaps campaign for improving nutritional intake in a small sample of families prior to the 2015 nationwide launch. A total of 49 participants from 14 families received information and materials during a two-week intervention period in November 2014 encouraging them to swap high sugar foods and drinks for low sugar alternatives. Daily dietary intake was reported with online food diaries over four stages, each two weeks in length: (i) baseline (no information provided), (ii) intervention when Sugar Swaps materials were accessible, (iii) immediate follow-up, and (iv) one year on from baseline. Data were analysed for sugar, glucose, fructose, sucrose, lactose, fat, saturated fat, carbohydrate, protein, salt, fibre, vitamin C, and energy. During the intervention, significant daily reductions of 32 g sugar, 11 g fat, and 236 kcal for each family member were observed, among others, and 61% of benefits achieved during the intervention period were maintained at immediate follow-up. Encouragingly, for children, reductions in sugar, sucrose, fat, saturated fat, carbohydrate, and energy were observed one year on. The Sugar Swaps Campaign is potentially an effective public health intervention for improving short- and long-term dietary behaviour for the whole family.


2012 ◽  
Vol 19 (4) ◽  
pp. 353-360 ◽  
Author(s):  
Tor Ivar Gjellesvik ◽  
Berit Brurok ◽  
Jan Hoff ◽  
Tom Tørhaug ◽  
Jan Helgerud

Sign in / Sign up

Export Citation Format

Share Document